Mizuho Medy Co.,Ltd.
Mizuho Medy Co.,Ltd. (4595.T) Stock Competitors & Peer Comparison
See (4595.T) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4595.T | ¥1,426.00 | +0.21% | 27.2B | 7.20 | ¥198.08 | +7.01% |
| 4502.T | ¥4,217.00 | +0.40% | 6.6T | 49.22 | ¥85.68 | +4.65% |
| 4507.T | ¥2,547.00 | +0.04% | 2.2T | 12.71 | ¥200.37 | +2.25% |
| 4523.T | ¥4,251.00 | -0.51% | 1.2T | 25.97 | ¥163.66 | +3.76% |
| 4581.T | ¥8,580.00 | -0.12% | 703.3B | 83.43 | ¥102.84 | N/A |
| 4506.T | ¥1,236.00 | -6.65% | 491B | 20.79 | ¥59.45 | N/A |
| 8129.T | ¥5,114.00 | +0.45% | 320.2B | 18.00 | ¥284.08 | +1.27% |
| 4530.T | ¥4,104.00 | +1.01% | 299.4B | 15.40 | ¥266.53 | +2.10% |
| 4540.T | ¥3,713.00 | -0.64% | 281.2B | 8.69 | ¥427.25 | +3.66% |
| 4887.T | ¥1,960.50 | +0.56% | 226.4B | 18.55 | ¥105.66 | +1.38% |
Stock Comparison
4595.T vs 4502.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4502.T has a market cap of 6.6T. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4502.T trades at ¥4,217.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4502.T's P/E ratio is 49.22. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4502.T's ROE of +0.01%. Regarding short-term risk, 4595.T is less volatile compared to 4502.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4502.T's competition here
4595.T vs 4507.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4507.T has a market cap of 2.2T. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4507.T trades at ¥2,547.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4507.T's P/E ratio is 12.71. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4507.T's ROE of +0.13%. Regarding short-term risk, 4595.T is less volatile compared to 4507.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4507.T's competition here
4595.T vs 4523.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4523.T has a market cap of 1.2T. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4523.T trades at ¥4,251.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4523.T's P/E ratio is 25.97. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4523.T's ROE of +0.05%. Regarding short-term risk, 4595.T is less volatile compared to 4523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4523.T's competition here
4595.T vs 4581.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4581.T has a market cap of 703.3B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4581.T trades at ¥8,580.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4581.T's P/E ratio is 83.43. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4581.T's ROE of +0.02%. Regarding short-term risk, 4595.T is more volatile compared to 4581.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4581.T's competition here
4595.T vs 4506.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4506.T has a market cap of 491B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4506.T trades at ¥1,236.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4506.T's P/E ratio is 20.79. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4506.T's ROE of +0.15%. Regarding short-term risk, 4595.T is less volatile compared to 4506.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4506.T's competition here
4595.T vs 8129.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 8129.T has a market cap of 320.2B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 8129.T trades at ¥5,114.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 8129.T's P/E ratio is 18.00. In terms of profitability, 4595.T's ROE is +0.22%, compared to 8129.T's ROE of +0.08%. Regarding short-term risk, 4595.T is less volatile compared to 8129.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 8129.T's competition here
4595.T vs 4530.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4530.T has a market cap of 299.4B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4530.T trades at ¥4,104.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4530.T's P/E ratio is 15.40. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4530.T's ROE of +0.08%. Regarding short-term risk, 4595.T is less volatile compared to 4530.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4530.T's competition here
4595.T vs 4540.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4540.T has a market cap of 281.2B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4540.T trades at ¥3,713.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4540.T's P/E ratio is 8.69. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4540.T's ROE of +0.11%. Regarding short-term risk, 4595.T is less volatile compared to 4540.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4540.T's competition here
4595.T vs 4887.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4887.T has a market cap of 226.4B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4887.T trades at ¥1,960.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4887.T's P/E ratio is 18.55. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4887.T's ROE of +0.12%. Regarding short-term risk, 4595.T is less volatile compared to 4887.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4887.T's competition here
4595.T vs 4516.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4516.T has a market cap of 222.6B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4516.T trades at ¥3,303.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4516.T's P/E ratio is 6.84. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4516.T's ROE of +0.14%. Regarding short-term risk, 4595.T is less volatile compared to 4516.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4516.T's competition here
4595.T vs 4547.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4547.T has a market cap of 182.5B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4547.T trades at ¥4,405.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4547.T's P/E ratio is 16.07. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4547.T's ROE of +0.06%. Regarding short-term risk, 4595.T is less volatile compared to 4547.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4547.T's competition here
4595.T vs 4551.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4551.T has a market cap of 177.7B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4551.T trades at ¥6,320.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4551.T's P/E ratio is 32.89. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4551.T's ROE of +0.05%. Regarding short-term risk, 4595.T is more volatile compared to 4551.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4595.T.Check 4551.T's competition here
4595.T vs 4553.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4553.T has a market cap of 165.6B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4553.T trades at ¥3,365.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4553.T's P/E ratio is 8.72. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4553.T's ROE of +0.11%. Regarding short-term risk, 4595.T is less volatile compared to 4553.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4553.T's competition here
4595.T vs 4521.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4521.T has a market cap of 145.8B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4521.T trades at ¥3,984.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4521.T's P/E ratio is 10.90. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4521.T's ROE of +0.09%. Regarding short-term risk, 4595.T is less volatile compared to 4521.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4521.T's competition here
4595.T vs 4534.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4534.T has a market cap of 114.5B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4534.T trades at ¥3,230.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4534.T's P/E ratio is 20.15. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4534.T's ROE of +0.04%. Regarding short-term risk, 4595.T is less volatile compared to 4534.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4534.T's competition here
4595.T vs 4559.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4559.T has a market cap of 93.3B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4559.T trades at ¥2,117.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4559.T's P/E ratio is 9.39. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4559.T's ROE of +0.12%. Regarding short-term risk, 4595.T is less volatile compared to 4559.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4559.T's competition here
4595.T vs 4569.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4569.T has a market cap of 88.6B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4569.T trades at ¥1,543.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4569.T's P/E ratio is 9.75. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4569.T's ROE of +0.07%. Regarding short-term risk, 4595.T is less volatile compared to 4569.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4569.T's competition here
4595.T vs 4886.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4886.T has a market cap of 69.9B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4886.T trades at ¥2,463.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4886.T's P/E ratio is 13.68. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4886.T's ROE of +0.08%. Regarding short-term risk, 4595.T is less volatile compared to 4886.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4886.T's competition here
4595.T vs 4577.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4577.T has a market cap of 35.6B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4577.T trades at ¥1,213.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4577.T's P/E ratio is 19.08. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4577.T's ROE of +0.04%. Regarding short-term risk, 4595.T is less volatile compared to 4577.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4577.T's competition here
4595.T vs 4554.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4554.T has a market cap of 34B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4554.T trades at ¥1,392.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4554.T's P/E ratio is 10.67. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4554.T's ROE of +0.07%. Regarding short-term risk, 4595.T is less volatile compared to 4554.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4554.T's competition here
4595.T vs 9273.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 9273.T has a market cap of 30.7B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 9273.T trades at ¥729.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 9273.T's P/E ratio is 8.74. In terms of profitability, 4595.T's ROE is +0.22%, compared to 9273.T's ROE of +0.14%. Regarding short-term risk, 4595.T is less volatile compared to 9273.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 9273.T's competition here
4595.T vs 2929.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 2929.T has a market cap of 25.9B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 2929.T trades at ¥890.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 2929.T's P/E ratio is 9.46. In terms of profitability, 4595.T's ROE is +0.22%, compared to 2929.T's ROE of +0.24%. Regarding short-term risk, 4595.T is less volatile compared to 2929.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 2929.T's competition here
4595.T vs 4538.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4538.T has a market cap of 19B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4538.T trades at ¥2,224.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4538.T's P/E ratio is -5.78. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4538.T's ROE of +0.07%. Regarding short-term risk, 4595.T is less volatile compared to 4538.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4538.T's competition here
4595.T vs 4574.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4574.T has a market cap of 14.3B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4574.T trades at ¥284.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4574.T's P/E ratio is -5.72. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4574.T's ROE of +0.11%. Regarding short-term risk, 4595.T is less volatile compared to 4574.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4574.T's competition here
4595.T vs 4597.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4597.T has a market cap of 11.5B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4597.T trades at ¥45.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4597.T's P/E ratio is -4.61. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4597.T's ROE of -1.24%. Regarding short-term risk, 4595.T is less volatile compared to 4597.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4597.T's competition here
4595.T vs 4512.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4512.T has a market cap of 10.3B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4512.T trades at ¥297.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4512.T's P/E ratio is 161.41. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4512.T's ROE of +0.01%. Regarding short-term risk, 4595.T is less volatile compared to 4512.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4512.T's competition here
4595.T vs 4524.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4524.T has a market cap of 8.9B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4524.T trades at ¥2,183.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4524.T's P/E ratio is 16.30. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4524.T's ROE of +0.04%. Regarding short-term risk, 4595.T is less volatile compared to 4524.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4524.T's competition here
4595.T vs 4582.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4582.T has a market cap of 7.7B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4582.T trades at ¥157.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4582.T's P/E ratio is -1.65. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4582.T's ROE of -0.91%. Regarding short-term risk, 4595.T is less volatile compared to 4582.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4582.T's competition here
4595.T vs 7079.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 7079.T has a market cap of 7.2B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 7079.T trades at ¥2,980.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 7079.T's P/E ratio is 7.85. In terms of profitability, 4595.T's ROE is +0.22%, compared to 7079.T's ROE of +0.23%. Regarding short-term risk, 4595.T is less volatile compared to 7079.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 7079.T's competition here
4595.T vs 4883.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4883.T has a market cap of 7B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4883.T trades at ¥91.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4883.T's P/E ratio is -3.19. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4883.T's ROE of -0.58%. Regarding short-term risk, 4595.T is less volatile compared to 4883.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4883.T's competition here
4595.T vs 4892.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4892.T has a market cap of 5.6B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4892.T trades at ¥673.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4892.T's P/E ratio is -6.21. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4892.T's ROE of -0.31%. Regarding short-term risk, 4595.T is less volatile compared to 4892.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4892.T's competition here
4595.T vs 4539.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4539.T has a market cap of 5.5B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4539.T trades at ¥1,538.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4539.T's P/E ratio is 18.82. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4539.T's ROE of +0.02%. Regarding short-term risk, 4595.T is less volatile compared to 4539.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4539.T's competition here
4595.T vs 4586.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4586.T has a market cap of 3.8B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4586.T trades at ¥74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4586.T's P/E ratio is -5.54. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4586.T's ROE of -0.49%. Regarding short-term risk, 4595.T is less volatile compared to 4586.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4586.T's competition here
4595.T vs 4541.T Comparison August 2025
4595.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4595.T stands at 27.2B. In comparison, 4541.T has a market cap of 2.5B. Regarding current trading prices, 4595.T is priced at ¥1,426.00, while 4541.T trades at ¥35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4595.T currently has a P/E ratio of 7.20, whereas 4541.T's P/E ratio is -0.00. In terms of profitability, 4595.T's ROE is +0.22%, compared to 4541.T's ROE of +0.13%. Regarding short-term risk, 4595.T is less volatile compared to 4541.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4595.T.Check 4541.T's competition here